• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汉坦病毒心肺综合征中细胞因子表达和纤溶酶原激活的纵向评估显示终末期疾病免疫调节功能障碍。

Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease.

机构信息

Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.

Bioinformatics Shared Resource Center, Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

出版信息

Viruses. 2021 Aug 12;13(8):1597. doi: 10.3390/v13081597.

DOI:10.3390/v13081597
PMID:34452463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8402847/
Abstract

Pathogenic New World orthohantaviruses cause hantavirus cardiopulmonary syndrome (HCPS), a severe immunopathogenic disease in humans manifested by pulmonary edema and respiratory distress, with case fatality rates approaching 40%. High levels of inflammatory mediators are present in the lungs and systemic circulation of HCPS patients. Previous studies have provided insights into the pathophysiology of HCPS. However, the longitudinal correlations of innate and adaptive immune responses and disease outcomes remain unresolved. This study analyzed serial immune responses in 13 HCPS cases due to Sin Nombre orthohantavirus (SNV), with 11 severe cases requiring extracorporeal membrane oxygenation (ECMO) treatment and two mild cases. We measured viral load, levels of various cytokines, urokinase plasminogen activator (uPA), and plasminogen activator inhibitor-1 (PAI-1). We found significantly elevated levels of proinflammatory cytokines and PAI-1 in five end-stage cases. There was no difference between the expression of active uPA in survivors' and decedents' cases. However, total uPA in decedents' cases was significantly higher compared to survivors'. In some end-stage cases, uPA was refractory to PAI-1 inhibition as measured by zymography, where uPA and PAI-1 were strongly correlated to lymphocyte counts and IFN-γ. We also found bacterial co-infection influencing the etiology and outcome of immune response in two cases. Unsupervised Principal Component Analysis and hierarchical cluster analyses resolved separate waves of correlated immune mediators expressed in one case patient due to a sequential co-infection of bacteria and SNV. Overall, a robust proinflammatory immune response, characterized by an imbalance in T helper 17 (Th17) and regulatory T-cells (Treg) subsets, was correlated with dysregulated inflammation and mortality. Our sample size is small; however, the core differences correlated to survivors and end-stage HCPS are instructive.

摘要

致病的新世界 orthohantaviruses 导致汉坦病毒心肺综合征(HCPS),这是一种严重的免疫发病人类疾病,表现为肺水肿和呼吸窘迫,病死率接近 40%。HCPS 患者的肺部和全身循环中存在高水平的炎症介质。先前的研究提供了对 HCPS 病理生理学的深入了解。然而,固有和适应性免疫反应与疾病结果的纵向相关性仍未解决。本研究分析了 13 例由于辛诺柏 orthohantavirus(SNV)引起的 HCPS 病例的系列免疫反应,其中 11 例严重病例需要体外膜氧合(ECMO)治疗,2 例轻度病例。我们测量了病毒载量、各种细胞因子、尿激酶纤溶酶原激活物(uPA)和纤溶酶原激活物抑制剂-1(PAI-1)的水平。我们发现 5 例终末期病例中促炎细胞因子和 PAI-1 水平显著升高。幸存者和死亡者病例中活性 uPA 的表达无差异。然而,死亡者病例中的总 uPA 明显高于幸存者。在一些终末期病例中,通过酶谱法测量时,uPA 对 PAI-1 抑制的反应性降低,uPA 和 PAI-1 与淋巴细胞计数和 IFN-γ强烈相关。我们还发现细菌合并感染影响免疫反应的病因和结果在两个病例中。无监督主成分分析和层次聚类分析确定了一个病例患者由于细菌和 SNV 的序贯合并感染而表达的相关免疫介质的单独波。总的来说,强大的促炎免疫反应,其特征是 Th17(Th17)和调节性 T 细胞(Treg)亚群的不平衡,与失调的炎症和死亡率相关。我们的样本量较小;然而,与幸存者和终末期 HCPS 相关的核心差异具有指导意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/8b07a29c414e/viruses-13-01597-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/51a093d908ab/viruses-13-01597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/941cc350f308/viruses-13-01597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/351fe2429ea1/viruses-13-01597-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/76f38300d618/viruses-13-01597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/37f1c5ae650c/viruses-13-01597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/4e91e6561920/viruses-13-01597-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/715b6d8e1371/viruses-13-01597-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/8b07a29c414e/viruses-13-01597-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/51a093d908ab/viruses-13-01597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/941cc350f308/viruses-13-01597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/351fe2429ea1/viruses-13-01597-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/76f38300d618/viruses-13-01597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/37f1c5ae650c/viruses-13-01597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/4e91e6561920/viruses-13-01597-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/715b6d8e1371/viruses-13-01597-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d340/8402847/8b07a29c414e/viruses-13-01597-g008.jpg

相似文献

1
Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease.汉坦病毒心肺综合征中细胞因子表达和纤溶酶原激活的纵向评估显示终末期疾病免疫调节功能障碍。
Viruses. 2021 Aug 12;13(8):1597. doi: 10.3390/v13081597.
2
Upregulation of P2YR, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome.P2YR、活性 uPA 和 PAI-1 的上调是汉坦病毒心肺综合征的重要组成部分。
Front Cell Infect Microbiol. 2018 May 23;8:169. doi: 10.3389/fcimb.2018.00169. eCollection 2018.
3
Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.感染辛诺柏汉坦病毒或安第斯汉坦病毒的鹿鼠的淋巴细胞和抗体反应差异。
J Virol. 2014 Aug;88(15):8319-31. doi: 10.1128/JVI.00004-14. Epub 2014 May 14.
4
The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.适应性免疫反应不会影响沙鼠汉坦病毒病或持续性感染。
Immunology. 2013 Oct;140(2):168-78. doi: 10.1111/imm.12116.
5
Elevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virus.由于辛诺柏病毒导致的严重汉坦病毒肺综合征患者体内细胞因子、凝血酶和纤溶酶原激活物抑制剂-1水平升高。
Viruses. 2015 Feb 10;7(2):559-89. doi: 10.3390/v7020559.
6
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.汉坦病毒心肺综合征中活性氧/氮物质生成增加。
J Virol. 2002 Aug;76(16):8347-59. doi: 10.1128/jvi.76.16.8347-8359.2002.
7
Hantavirus Cardiopulmonary Syndrome in Canada.加拿大汉坦病毒心肺综合征。
Emerg Infect Dis. 2020 Dec;26(12):3020-3024. doi: 10.3201/eid2612.202808.
8
Tracing Transmission of Sin Nombre Virus and Discovery of Infection in Multiple Rodent Species.追溯辛诺柏病毒的传播途径及在多种啮齿动物物种中的感染发现。
J Virol. 2021 Nov 9;95(23):e0153421. doi: 10.1128/JVI.01534-21. Epub 2021 Sep 22.
9
Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome.从汉坦病毒心肺综合征康复后体内的中和抗体及辛诺柏病毒RNA
Emerg Infect Dis. 2004 Mar;10(3):478-82. doi: 10.3201/eid1003.020821.
10
Humoral immune responses in the hantavirus cardiopulmonary syndrome.汉坦病毒心肺综合征中的体液免疫反应。
J Infect Dis. 2000 Jul;182(1):43-8. doi: 10.1086/315657. Epub 2000 Jun 27.

引用本文的文献

1
Pathogenicity and virulence of Rodent-Borne Orthohantaviruses.啮齿动物传播的正汉坦病毒的致病性和毒力
Virulence. 2025 Dec;16(1):2553784. doi: 10.1080/21505594.2025.2553784. Epub 2025 Sep 4.
2
Expression Profile of Human Renal Mesangial Cells Is Altered by Infection with Pathogenic Puumala Orthohantavirus.人肾小球系膜细胞的表达谱受致病性普马拉型正粘病毒感染的影响。
Viruses. 2022 Apr 15;14(4):823. doi: 10.3390/v14040823.

本文引用的文献

1
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.SARS-CoV-2 的病理生理学:西奈山 COVID-19 尸检经验。
Mod Pathol. 2021 Aug;34(8):1456-1467. doi: 10.1038/s41379-021-00793-y. Epub 2021 Apr 1.
2
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.住院 COVID-19 患者的血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1。
Sci Rep. 2021 Jan 15;11(1):1580. doi: 10.1038/s41598-020-80010-z.
3
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
白细胞介素-6 转导信号诱导细胞因子释放综合征中的血管内皮细胞产生纤溶酶原激活物抑制剂-1。
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22351-22356. doi: 10.1073/pnas.2010229117. Epub 2020 Aug 21.
4
Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.
5
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.COVID-19 肺炎患者中标记的 T 细胞激活、衰老、衰竭和向 TH17 的倾斜。
Nat Commun. 2020 Jul 6;11(1):3434. doi: 10.1038/s41467-020-17292-4.
6
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.用于治疗新冠肺炎和急性呼吸窘迫综合征患者的调节性T细胞:两例病例报告
Ann Intern Med. 2020 Nov 17;173(10):852-853. doi: 10.7326/L20-0681. Epub 2020 Jul 6.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
A critical role for plasminogen in inflammation.纤溶酶原在炎症中起着关键作用。
J Exp Med. 2020 Apr 6;217(4). doi: 10.1084/jem.20191865.
9
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer.转移性乳腺癌患者血液中尿激酶型纤溶酶原激活物(uPA)的预后相关性。
Sci Rep. 2019 Feb 19;9(1):2318. doi: 10.1038/s41598-018-37259-2.
10
Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome.与汉坦病毒肺综合征严重程度和结局相关的血清标志物。
J Infect Dis. 2019 May 5;219(11):1832-1840. doi: 10.1093/infdis/jiz005.